Posted by Michael Wonder on 25 Jun 2024
EMA publishes agenda for June 24-27 2024 CHMP meeting
24 June 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Erdafitinib
- Enzalutamide
- Adrenaline
- Masitinib mesylate
- Respiratory syncytial virus vaccine
- Nilotinib hydrochloride monohydrate
- Odronextamab
- Crovalimab
- Ustekinumab
- Flortaucipir (F 18)
- Sotatercept
